Troels Marstrand

Troels Marstrand

Auto-generated profile, based on publicly available information

Troels Marstrand

LEO Pharma, Ballerup, Denmark

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JBJan Christian Bryne
Jan Christian Bryne
EVEivind Valen
Eivind Valen
MTMan-Hung Eric Tang
Man-Hung Eric Tang
TMTroels Marstrand
Troels Marstrand
OWOle Winther
Ole Winther
ASAlbin Sandelin
Albin Sandelin
JASPAR is a popular open-access database for matrix models describing DNA-binding preferences for transcription factors and other DNA patterns. With its third major release, JASPAR has been expanded and equipped with additional functions aimed at both casual and power users. The heart of the JASPAR database—the JASPAR CORE sub-database—has increased by 12% in size, and three new specialized sub-databases have been added. New functions include clustering of matrix models by similarity, generation of random matrices by sampling from selected sets of existing models and a language-independent Web Service applications programming interface for matrix retrieval. JASPAR is available at http://jaspar.genereg.net .

1 April 2010 in Environmental Health Perspectives
Verified
Journal Article
Open access
JRJerome Ruzzin
Jerome Ruzzin
RPRasmus Petersen
Rasmus Petersen
EMEmmanuelle Meugnier
Emmanuelle Meugnier
LMLise Madsen
Lise Madsen
ELErik-Jan Lock
Erik-Jan Lock
LFLivar Frøyland
Livar Frøyland
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

15 January 2010 in Genome Medicine
Verified
Journal Article
Open access
PDF file
NSNathan A Stephens
Nathan A Stephens
IGIain Gallagher
Iain Gallagher
OROlav Rooyackers
Olav Rooyackers
RSRichard J Skipworth
Richard J Skipworth
BTBen H Tan
Ben H Tan
JTJames A Timmons
James A Timmons
Cancer cachexia is a multi-organ tissue wasting syndrome that contributes to morbidity and mortality in many cancer patients. Skeletal muscle loss represents an established key feature yet there is no molecular understanding of the disease process. In fact, the postulated molecular regulators of cancer cachexia originate largely from pre-clinical models and it is unclear how these translate to the clinical environment.

11 December 2008 in Genome Research
Verified
Journal Article
Open access
PDF file
EVEivind Valen
Eivind Valen
GPGiovanni Pascarella
Giovanni Pascarella
ACAlistair Chalk
Alistair Chalk
NMNorihiro Maeda
Norihiro Maeda
MKMiki Kojima
Miki Kojima
Piero CarninciPiero Carninci
Piero Carninci
Finding and characterizing mRNAs, their transcription start sites (TSS), and their associated promoters is a major focus in post-genome biology. Mammalian cells have at least 5–10 magnitudes more TSS than previously believed, and deeper sequencing is necessary to detect all active promoters in a given tissue. Here, we present a new method for high-throughput sequencing of 5′ cDNA tags—DeepCAGE: merging the Cap Analysis of Gene Expression method with ultra-high-throughput sequence technology. We apply DeepCAGE to characterize 1.4 million sequenced TSS from mouse hippocampus and reveal a wealth of novel core promoters that are preferentially used in hippocampus: This is the most comprehensive promoter data set for any tissue to date. Using these data, we present evidence indicating a key role for theArnt2transcription factor in hippocampus gene regulation. DeepCAGE can also detect promoters used only in a small subset of cells within the complex tissue.

19 February 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YLYawen Liu
Yawen Liu
HGHui Gao
Hui Gao
TMTroels Torben Marstrand
Troels Torben Marstrand
ASAnders Ström
Anders Ström
EVEivind Valen
Eivind Valen
KDKarin Dahlman-Wright
Karin Dahlman-Wright
In this article, we have applied the ChIP-on-chip approach to pursue a large scale identification of ERα- and ERβ-binding DNA regions in intact chromatin. We show that there is a high degree of overlap between the regions identified as bound by ERα and ERβ, respectively, but there are also regions that are bound by ERα only in the presence of ERβ, as well as regions that are selectively bound by either receptor. Analysis of bound regions shows that regions bound by ERα have distinct properties in terms of genome landscape, sequence features, and conservation compared with regions that are bound by ERβ. ERβ-bound regions are, as a group, located more closely to transcription start sites. ERα- and ERβ-bound regions differ in sequence properties, with ERα-bound regions having an overrepresentation of TA-rich motifs including forkhead binding sites and ERβ-bound regions having a predominance of classical estrogen response elements (EREs) and GC-rich motifs. Differences in the properties of ER bound regions might explain some of the differences in gene expression programs and physiological effects shown by the respective estrogen receptors.

1 February 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AFAmin Feizpour
Amin Feizpour
TMTroels Marstrand
Troels Marstrand
LBLouise Bastholm
Louise Bastholm
SEStefan Eirefelt
Stefan Eirefelt
CEConor L. Evans
Conor L. Evans